Increased Drug Outsourcing To China, India A Concern In U.S.
This article was originally published in PharmAsia News
Executive Summary
America's increasing reliance on drugs produced in other countries, primarily China and India, is causing concern among U.S. lawmakers and some health experts. They note that no antibiotics are being made in the United States any more and the active pharmaceutical ingredients for dozens of other vital drugs also come from those two countries. U.S. FDA records show that of 1,154 production plants listed in generics applications, 43 percent were in China, 39 percent in India. Sen. Sherrod Brown, D-Ohio, cited a lack of regulations covering outsourcing as a problem at a time of concern about bioterrorism and counterfeits. (Click here for more